CClinicalTrials.gg
CompletedNCT06390514Updated May 13, 2025

The Benefits of Vibrating Floors for Deaf Children

An interventional study of vibrating floor and No vibrating floor in Deaf Children, sponsored by Université Catholique de Louvain. Completed at 1 site in Belgium. Open to participants aged 3 Years to 14 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-13.

Sponsored by Université Catholique de Louvain · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
3 Years to 14 Years
Sex
All
01

Study summary

In view of the difficulties observed in the oral language development of deaf children, it is essential to offer them appropriate and effective care as early as possible. One of the modalities frequently used clinically to stimulate this perception of language in the deaf child is to use the tactile sense via vibrations. One such tactile tool used by speech therapists is the vibrating floor, which enables the child to feel sounds through the vibrations perceived by his or her body. Although used in many institutions, there is very little scientific evidence to date of the effectiveness of using the vibrating floor with deaf children.

02

Conditions studied

  • Deaf Children

Keywords

  • vibrating floor benefits
03

In context

Lead sponsor

Université Catholique de Louvain is the lead sponsor of 144 studies on the registry; 57 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Deaf children whose project is to develop oral French language skills
  • Deaf children with cochlear implants or hearing aids
  • Children with previous experience of the vibrating floor

Exclusion criteria

Exclusion Criteria:

  • intellectual disability
  • impairment
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
15 participants (actual)

Study arms

  • Experimental
    with the vibrating floor

    Other: vibrating floor · Other: No vibrating floor

  • Active comparator
    without the vibrating floor

    Other: vibrating floor · Other: No vibrating floor

Interventions

  • Othervibrating floor

    activities with vibrating floor

  • OtherNo vibrating floor

    activities without vibrating floor

06

What researchers measure

Primary outcomes

  1. Language assessment

    sound detection, discrimination and repetition

    Time frame: Throughout the entire study, approximately during 24 months

Secondary outcomes

  1. Questionnaire on feelings and well-being

    feelings about vibrating floor

    Time frame: Throughout the entire study, approximately during 24 months

07

Study locations

1 site
  • Bragard Anne
    Louvain-la-Neuve, Brabant 1348, Belgium
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 13, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06390514
Lead sponsor
Université Catholique de Louvain
Responsible party
Sponsor
First posted
Apr 30, 2024
Start date
Jan 8, 2024
Primary completion
Jan 15, 2025
Completion
Jan 15, 2025
Last update
May 13, 2025

Study contacts

Anne Bragard, PhD
principal investigator · Université Catholique de Louvain

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion